Albemarle — Nov 6, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915913-24-000156
Showing in the filing
Net sales - Recent pricing scenario
“$5.5 - $6.2 billion”
Period
FY2024
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 27
Annual run-rate cost and productivity improv…
“$300 million to $400 million”
Annual run-rate cost savings
“$300 million to $400 million”
Global workforce reduction
“6-7%”
Charge related to cost and operating structu… for Q4 FY2024
“a charge primarily related to severance and related benefit costs”
Capital expenditures for FY2025
“$800 million to $900 million”
Total company full-year 2024 net sales for FY2024
“at the lower-end of that range”
Average lithium market price ($/kg LCE) - Re… for FY2024
“$12-15”
Average lithium market price ($/kg LCE) (a) for FY2024
“$12-15”
Average lithium market price ($/kg LCE) - Q4… for FY2024
“~$20”
Average lithium market price ($/kg LCE) - H2… for FY2024
“~$25”
Net sales for FY2024
“$5.5 - $6.2 billion”
Net sales - Recent pricing scenario for FY2024
“$5.5 - $6.2 billion”
Net sales - Q4 2023 average scenario for FY2024
“$6.1 - $6.8 billion”
Net sales for Q4 FY2023
“$6.1 - $6.8 billion”
Net sales - H2 2023 average scenario for FY2024
“$6.9 - $7.6 billion”
Net sales for FY2023
“$6.9 - $7.6 billion”
Adjusted EBITDA - Recent pricing scenario for FY2024
“$0.9 - $1.2 billion”
Adjusted EBITDA (b)(c) for FY2024
“$0.9 - $1.2 billion”
Adjusted EBITDA - Q4 2023 average scenario for FY2024
“$1.6 - $1.8 billion”
Adjusted EBITDA (b)(c) for Q4 FY2023
“$1.6 - $1.8 billion”
Adjusted EBITDA - H2 2023 average scenario for FY2024
“$2.3 - $2.6 billion”
Adjusted EBITDA (b)(c) for FY2023
“$2.3 - $2.6 billion”
Weighted-average common shares outstanding (… for FY2024
“~118 million”
Weighted-average common shares outstanding (… for Q4 FY2023
“~118 million”
Weighted-average common shares outstanding (… for FY2024
“135 - 139 million”
Weighted-average common shares outstanding (… for FY2023
“135 - 139 million”
Capital expenditures for the full-year 2024 for FY2024
“at the lower-end of the prior outlook range of $1.7 billion to $1.8 billion”
Exhibit 99.1 · the passage around this item
… earlier in the release
All other corporate outlook considerations are unchanged. Total Corporate FY 2024E Including Energy Storage Scenarios Observed market price case (a) Recent pricing Q4 2023 average H2 2023 average Average lithium market price ($/kg LCE) (a) $12-15 ~$20 ~$25 Net sales $5.5 - $6.2 billion $6.1 - $6.8 billion $6.9 - $7.6 billion Adjusted EBITDA (b)(c) $0.9 - $1.2 billion $1.6 - $1.8 billion $2.3 - $2.6 billion Weighted-average common shares outstanding (diluted) (d) ~118 million ~118 million 135 - 139 million (a) Price represents blend of relevant Asia and China market indices for the periods referenced. (b) The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. See “Additional Information regarding Non-GAAP Measures” for more information. (c) Presented under updated adjusted EBITDA definition as of 2024. FY23 adjusted EBITDA under updated definition would be $3.5B. See Non-GAAP Reconciliations for further details. (d) Each quarter, Albemarle will report the more dilutive of either: 1) adding the underlying shares in the mandatory to the share count or 2) reducing Albemarle’s net income to common shareholders by the mandatory dividend. The 20-day volume-weighted average common share price will be used in determi
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.